Nothing Special   »   [go: up one dir, main page]

BRPI0810806A2 - Método para tratar uma lesão cutânea em um indivíduo - Google Patents

Método para tratar uma lesão cutânea em um indivíduo

Info

Publication number
BRPI0810806A2
BRPI0810806A2 BRPI0810806-4A2A BRPI0810806A BRPI0810806A2 BR PI0810806 A2 BRPI0810806 A2 BR PI0810806A2 BR PI0810806 A BRPI0810806 A BR PI0810806A BR PI0810806 A2 BRPI0810806 A2 BR PI0810806A2
Authority
BR
Brazil
Prior art keywords
individual
treating cutaneous
cutaneous injury
injury
treating
Prior art date
Application number
BRPI0810806-4A2A
Other languages
English (en)
Inventor
Steven Martin Ogbourne
Andreas Suhrbier
James Harrison Aylward
Original Assignee
Peplin Research Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39925109&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0810806(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AU2007902266A external-priority patent/AU2007902266A0/en
Application filed by Peplin Research Pty Ltd filed Critical Peplin Research Pty Ltd
Publication of BRPI0810806A2 publication Critical patent/BRPI0810806A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0810806-4A2A 2007-04-30 2008-04-30 Método para tratar uma lesão cutânea em um indivíduo BRPI0810806A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2007902266A AU2007902266A0 (en) 2007-04-30 Treatment of virally induced lesions
PCT/AU2008/000596 WO2008131491A1 (en) 2007-04-30 2008-04-30 Treatment of virally induced lesions

Publications (1)

Publication Number Publication Date
BRPI0810806A2 true BRPI0810806A2 (pt) 2014-10-29

Family

ID=39925109

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810806-4A2A BRPI0810806A2 (pt) 2007-04-30 2008-04-30 Método para tratar uma lesão cutânea em um indivíduo

Country Status (23)

Country Link
US (1) US9895334B2 (pt)
EP (1) EP2152261B1 (pt)
JP (1) JP5497629B2 (pt)
KR (1) KR101485883B1 (pt)
CN (1) CN101742996B (pt)
AU (1) AU2008243705B2 (pt)
BR (1) BRPI0810806A2 (pt)
CA (1) CA2685473C (pt)
CY (1) CY1119269T1 (pt)
DK (1) DK2152261T3 (pt)
ES (1) ES2564173T3 (pt)
HK (1) HK1134450A1 (pt)
HR (1) HRP20160181T1 (pt)
HU (1) HUE028713T2 (pt)
IL (1) IL201796A (pt)
MX (1) MX2009011865A (pt)
MY (1) MY154484A (pt)
NZ (1) NZ580702A (pt)
PL (1) PL2152261T3 (pt)
RU (1) RU2506951C2 (pt)
SI (1) SI2152261T1 (pt)
UA (1) UA98328C2 (pt)
WO (1) WO2008131491A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ801700A0 (en) 2000-06-07 2000-06-29 Peplin Research Pty Ltd Enzyme and viral activation
NZ583157A (en) 2004-12-13 2011-12-22 Leo Lab Ltd Treatment of solid cancers with angeloyl substituted ingenanes
RU2506951C2 (ru) 2007-04-30 2014-02-20 Лео Лэборетериз Лимитед Лечение повреждений, индуцированных вирусом
AU2010213362B2 (en) * 2009-02-13 2015-07-02 Leo Laboratories Limited Skin treatment
PT2558435T (pt) 2010-04-16 2017-07-24 Leo Pharma As Mebutato de ingenol cristalino ortorrômbico
WO2012080466A2 (en) 2010-12-17 2012-06-21 Leo Pharma A/S Ingenols for treating seborrheic keratosis
CA2822312A1 (en) * 2010-12-22 2012-06-28 Gunnar Grue-Sorensen 3-acyl-ingenols ii
CN104529827B (zh) 2010-12-22 2016-08-24 利奥实验室有限公司 巨大戟二萜醇-3-酰化物iii和巨大戟二萜醇-3-氨基甲酸酯
BR112013015877A2 (pt) 2010-12-22 2018-06-05 Leo Laboratories Ltd composto, uso de um composto, métodos de prevenção. tratamento, melhora ou profilaxia de distúrbios fisiológicos ou doenças, e de tratamento ou melhora de indicações cosméticas, e, composição farmacêutica.
WO2012176015A1 (en) 2011-06-24 2012-12-27 Leo Pharma A/S Methods for treating uv-damaged skin and scc tumors and for removing tattoos with topical ingenol mebutate
KR101406201B1 (ko) * 2011-10-19 2014-06-12 한국생명공학연구원 인제난 타입의 디테르펜 화합물 및 이를 포함하는 바이러스 감염 질환의 치료 또는 예방용 약학적 조성물
AU2013225633B2 (en) * 2012-03-02 2017-11-23 Amazonia Fitomedicamentos Ltda. Ingenol derivatives in the reactivation of latent HIV
US20130251782A1 (en) * 2012-03-22 2013-09-26 Leo Laboratories Limited Topical application of ingenol mebutate with occlusion
EP2864290B1 (en) * 2012-06-26 2017-06-14 Leo Laboratories Limited 3-o-heteroaryl-ingenol
WO2014090859A1 (en) * 2012-12-12 2014-06-19 Leo Laboratories Limited Gel compositions
GB201222406D0 (en) * 2012-12-12 2013-01-23 Leo Lab Ltd Gel compositions
GB201222405D0 (en) * 2012-12-12 2013-01-23 Leo Lab Ltd Gel compositions
GB201222403D0 (en) * 2012-12-12 2013-01-23 Leo Lab Ltd Gel compositions
WO2014198807A1 (en) * 2013-06-12 2014-12-18 Leo Laboratories Limited A topical composition
KR101520428B1 (ko) * 2013-11-22 2015-05-14 충남대학교산학협력단 대극 추출물을 유효성분으로 포함하는 항인플루엔자용 조성물
CN104188979B (zh) * 2014-08-11 2017-01-11 泰州祥泰康华医药科技有限公司 闭花木酮Cleistanone的O-(吗啉基)乙基衍生物在制备治疗缺血性脑损伤药物中的应用
CN104523705A (zh) * 2014-12-10 2015-04-22 南京大学 闭花木酮的o-(咪唑基)乙基衍生物在制备抗病毒药物中的应用
WO2017156350A1 (en) 2016-03-09 2017-09-14 K-Gen, Inc. Methods of cancer treatment
JP7495679B2 (ja) * 2019-10-03 2024-06-05 国立大学法人京都大学 ヒトパピローマウイルス性疣贅に対する貼付剤
EP3915549A1 (en) * 2020-05-26 2021-12-01 Merck Patent GmbH Senescence inducers for use in the treatment and/or prevention of virus induced diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804203A (en) * 1994-12-21 1998-09-08 Cosmederm Technologies Topical product formulations containing strontium for reducing skin irritation
RU2174396C2 (ru) * 1997-03-20 2001-10-10 Панацея Биотек Лтд. Фармацевтическая композиция для подавления и лечения аноректальных и ободочно-кишечных болезней
AUPQ801700A0 (en) * 2000-06-07 2000-06-29 Peplin Research Pty Ltd Enzyme and viral activation
NZ583157A (en) * 2004-12-13 2011-12-22 Leo Lab Ltd Treatment of solid cancers with angeloyl substituted ingenanes
KR20080080539A (ko) * 2005-11-14 2008-09-04 페플린 리서치 피티이 리미티드 암을 치료하기 위한 기타 제제와 병합한 안젤로일-치환된인게난의 용도
GB0525680D0 (en) 2005-12-16 2006-01-25 Peplin Ltd Therapeutic compositions
RU2506951C2 (ru) 2007-04-30 2014-02-20 Лео Лэборетериз Лимитед Лечение повреждений, индуцированных вирусом

Also Published As

Publication number Publication date
CA2685473A1 (en) 2008-11-06
WO2008131491A1 (en) 2008-11-06
CY1119269T1 (el) 2018-02-14
HK1134450A1 (zh) 2010-04-30
UA98328C2 (uk) 2012-05-10
CA2685473C (en) 2015-09-01
CN101742996A (zh) 2010-06-16
NZ580702A (en) 2012-03-30
US9895334B2 (en) 2018-02-20
AU2008243705A1 (en) 2008-11-06
IL201796A0 (en) 2010-06-16
KR20100017464A (ko) 2010-02-16
RU2009144100A (ru) 2011-06-10
EP2152261A4 (en) 2013-01-02
MX2009011865A (es) 2009-12-04
AU2008243705B2 (en) 2013-10-10
CN101742996B (zh) 2013-08-21
HRP20160181T1 (hr) 2016-05-06
DK2152261T3 (en) 2016-03-07
SI2152261T1 (sl) 2016-05-31
US20100204318A1 (en) 2010-08-12
HUE028713T2 (en) 2016-12-28
PL2152261T3 (pl) 2016-06-30
ES2564173T3 (es) 2016-03-18
RU2506951C2 (ru) 2014-02-20
JP2010524978A (ja) 2010-07-22
JP5497629B2 (ja) 2014-05-21
IL201796A (en) 2016-11-30
MY154484A (en) 2015-06-30
EP2152261B1 (en) 2015-12-09
KR101485883B1 (ko) 2015-01-27
EP2152261A1 (en) 2010-02-17

Similar Documents

Publication Publication Date Title
BRPI0810806A2 (pt) Método para tratar uma lesão cutânea em um indivíduo
BRPI0818011A2 (pt) Método e dispositivo para associar objetos
BRPI0912830A2 (pt) aparelho e método para aliviar obstrução de uma via aérea
BRPI0910587A2 (pt) método e aparelho para eletrogalvanização
BRPI0820212A2 (pt) Dispositivo para tratamento de fraturas, método para tratamento de fraturas, e, kit para tratamento de fraturas
BRPI0917828A2 (pt) método e dispositivo para prevenção de ferimentos de torção de tornozelo
BRPI0721502A2 (pt) Método para tratamento de uma formação fraturada
BRPI0908260A2 (pt) Dispositivo para tratamento térmico
BRPI0811589A2 (pt) Composição farmacêutica e método para tratar câncer
BRPI0819075A2 (pt) Método para tratar púrpura em um indivíduo e método para diminuir a púrpura em um indivíduo antes de um procedimento cirúrgico
BRPI0818056A2 (pt) Aparelho e métodos para hemodiálise
BRPI0921720A2 (pt) método e aparelho para entralaçamento de bloco de dados
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI0819678A2 (pt) método para tratar cmt e distúrbios relacionados
BRPI0815283A2 (pt) Equipamento para o tratamento da biomassa, método para o tratamento da biomassa, biomassa tratada e hidrolisado
BRPI0905996A2 (pt) "método e aparelho para secagem contínua"
BRPI0911077A2 (pt) método para tratamento de biomassa
BRPI1008617A2 (pt) método e aparelho para lipoaspiração
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
BRPI0913280A2 (pt) dispositivo e método para o tratamento de fluxos de artigos
BRPI1011325A2 (pt) composições e métodos para o tratamento de inflamação
BRPI0907227A2 (pt) Método e dispositivo para assinatura
BRPI0908715A2 (pt) métodos para tratamento da psoríase
BRPI0918294A2 (pt) dispositivo e método para produzir explosões
BRPI0924469A2 (pt) método para esterilizar calçados e aparelho para esterilizar calçados

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: AKTIESELSKABET AF 30. APRIL 2003 (DK)

B25A Requested transfer of rights approved

Owner name: LEO LABORATORIES LIMITED (IE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time
B350 Update of information on the portal [chapter 15.35 patent gazette]